Rapid Theraptic Scince Lab Stock Price, News & Analysis
RTSL
OTC Link
Company Description
Welcome to the overview page for Rapid Theraptic Scince Lab (RTSL), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Rapid Theraptic Scince Lab.
Financial Highlights
$0
Revenue (TTM)
-$1.8M
Net Income (TTM)
-$1.2M
Operating Cash Flow
0.05
$0
Gross Profit (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Rapid Theraptic Scince Lab (RTSL)?
The current stock price of Rapid Theraptic Scince Lab (RTSL) is $0.006 as of January 26, 2026.
What is the market cap of Rapid Theraptic Scince Lab (RTSL)?
The market cap of Rapid Theraptic Scince Lab (RTSL) is approximately 57.0K. Learn more about what market capitalization means .
What is the revenue (TTM) of Rapid Theraptic Scince Lab (RTSL) stock?
The trailing twelve months (TTM) revenue of Rapid Theraptic Scince Lab (RTSL) is $0.
What is the net income of Rapid Theraptic Scince Lab (RTSL)?
The trailing twelve months (TTM) net income of Rapid Theraptic Scince Lab (RTSL) is -$1.8M.
What is the operating cash flow of Rapid Theraptic Scince Lab (RTSL)?
The operating cash flow of Rapid Theraptic Scince Lab (RTSL) is -$1.2M. Learn about cash flow.
What is the current ratio of Rapid Theraptic Scince Lab (RTSL)?
The current ratio of Rapid Theraptic Scince Lab (RTSL) is 0.05, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of Rapid Theraptic Scince Lab (RTSL)?
The gross profit of Rapid Theraptic Scince Lab (RTSL) is $0 on a trailing twelve months (TTM) basis.